Two Prominent Professors to Keynote 25th Annual Neurotech Leaders Forum

News Source: Neurotech Reports

SAN FRANCISCO, Calif., Aug. 11, 2025 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that two prominent figures in the field of neurotechnology will keynote the 2025 Neurotech Leaders Forum, which takes place November 5-6 in San Francisco. Edward Chang, chair of the department of neurological surgery at UC San Francisco, will discuss future applications of implanted brain sensing and stimulation devices.

(L-R) Prof. Edward Chang, M.D., and J. Thomas Mortimer, Ph.D.
Image caption: Prof. Edward Chang, M.D., from UC San Francisco (L) and J. Thomas Mortimer, Ph.D., Emeritus from Case Western University (R) will keynote the 2025 Neurotech Leaders Forum in San Francisco.

J. Thomas Mortimer, emeritus professor of biomedical engineering at Case Western Reserve University, will discuss his history as a pioneer developing implanted neurostimulation systems for chronic pain, diaphragm pacing, and bladder control.

The 25th annual event will also feature sessions devoted to the business of neuromodulation, the investment outlook for neurotechnology, the convergence of AI and BCI technologies, new realities in regulatory and reimbursement policies, and several other topics. Neurotech Reports editors James Cavuoto, Jeremy Koff, JoJo Platt, and Victor Pikov will moderate panel discussions with key industry leaders.

Several panelists and presenters were recently added to the agenda for the two-day conference. New speakers include Ryan Field, CEO of Kernel; Andreas Forland, CEO of Cognixion; and Oliver Armitage, newly appointed vice president of Axoft. Venture capital professionals participating in the meeting include Mir Imran, managing partner at InCube Ventures, and Lu Zhang, founder and managing partner of Fusion Fund.

Among the new presenters this year are Emile Radyte, CEO of Samphire Neuroscience in the U.K., which has developed a wearable neuromodulation device for treatment of PMS and menstrual pain and Tetiana Aleksandrova, CEO of Subsense, Inc., which is developing a nonsurgical nanoparticle-based BCI system.

The Platinum Sponsor at this year’s event is Cirtec Medical. Micro Systems Technology is the Gold Sponsor. Silver sponsors include Velentium and Valtronic.

“As we celebrate our 25th year covering the neurotechnology industry, it’s gratifying to have Prof. Mortimer, one of the founders of the field, and Prof. Chang, one of the most promising researchers and entrepreneurs, talk about the past and future of our industry,” said James Cavuoto, editor and publisher of Neurotech Reports.

Neurotech Reports has extended the early-bird registration deadline until September 12, 2025.

Also, Neurotech Reports still has openings for a small number of startup and early-stage firms who would like to present during one of two Entrepreneur Panels at the conference.

To apply, visit this link: https://www.neurotechreports.com/pages/nlf-presenter-application.html

For more information, contact Neurotech Reports at 415 546 1259 or visit https://www.neurotechreports.com/.

MULTIMEDIA:

Image link for media: https://www.Send2Press.com/300dpi/25-0811-s2p-ntpchangmortimer-300dpi.jpg

Image caption: Prof. Edward Chang, M.D., from UC San Francisco (L) and J. Thomas Mortimer, Ph.D., Emeritus from Case Western University (R) will keynote the 2025 Neurotech Leaders Forum in San Francisco.

Neurotech Reports logo: https://www.neurotechreports.com//images/neurotech_business_SimpleBug.png


This press release was issued on behalf of the news source (Neurotech Reports), who is solely responsible for its accuracy, by Send2Press Newswire.

To view the original story, visit: https://www.send2press.com/wire/two-prominent-professors-to-keynote-25th-annual-neurotech-leaders-forum/

Copr. © 2025 Send2Press® Newswire, Calif., USA. -- REF: S2P STORY ID: S2P128348 FCN24-3B

 

INFORMATION BELOW THIS PAGE, IF ANY, IS UNRELATED TO THIS PRESS RELEASE.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.